Matches in Nanopublications for { ?s ?p "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP290821.RAN3Z0fWz0J4-pUK5kjOGGCzSZlMw-FAB1l6e1M6ogcq0130_assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290821.RAN3Z0fWz0J4-pUK5kjOGGCzSZlMw-FAB1l6e1M6ogcq0130_provenance.
- assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1110101.RATmDI-5lAKWJM9pUsDq9klio6WTg9Z07jfqMVRzPcmxc130_assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1110101.RATmDI-5lAKWJM9pUsDq9klio6WTg9Z07jfqMVRzPcmxc130_provenance.
- NP1110100.RADBct6UYd2IAjofmKPiVwaINpymcfaLHeZI-KpGtuBus130_assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1110100.RADBct6UYd2IAjofmKPiVwaINpymcfaLHeZI-KpGtuBus130_provenance.
- NP721436.RAJt3TZ572CP2An6WYOzimXjPKpttNYlIQiX4iIERw0wo130_assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721436.RAJt3TZ572CP2An6WYOzimXjPKpttNYlIQiX4iIERw0wo130_provenance.
- NP721661.RAMs6Xh12XbiK3OkgidfUaihlFxuFTM1zB3KShvJ3_TQc130_assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721661.RAMs6Xh12XbiK3OkgidfUaihlFxuFTM1zB3KShvJ3_TQc130_provenance.
- NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_provenance.
- NP1110105.RA8JoJJ5sXdOkcGK2lIe581Uz-P8z69LGZRVrc_87Z1jo130_assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1110105.RA8JoJJ5sXdOkcGK2lIe581Uz-P8z69LGZRVrc_87Z1jo130_provenance.